ONESOURCE · Concall Summary
ONESOURCE SPECL PHARMA L
The investor presentation for Onesource Specialty Pharma Limited, dated September 3, 2026, was uploaded to the company's website following an investor meeting held on the same day at the company's manufacturing facility in Bengaluru. The document includes the company's contact information, stock exchange details, and a notice to investors regarding the presentation. The meeting was scheduled as previously communicated on August 31, 2026, and the presentation is available at the specified website link. The document was signed by Trisha A, the company secretary and compliance officer, on September 3, 2026.
The tone of the document is neutral, as it provides factual information about the investor presentation and meeting without expressing positive or negative sentiment.
View source filing →Earlier concalls
- 2026-07-31 — OneSource Specialty Pharma Limited reported strong financial results for Q1 FY27, with revenues of INR 4,490 million, re…
- 2026-05-13 — OneSource Specialty Pharma Limited reported its Q4FY26 results, highlighting a 47% quarter-on-quarter increase in revenu…
- 2026-01-30 — OneSource Specialty Pharma Limited's Q3 FY '26 earnings call highlighted revenue deferrals due to delayed Canadian regul…
See ONESOURCE's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free